ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Novita Sa

Novita Sa (0LWS)

46.00
0.00
(0.00%)
Closed 05 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
46.00
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
46.00 52 Week Range 46.00
Market Cap
Previous Close
46.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
2,500,000
Dividend Yield
-
PE Ratio
4.94
Earnings Per Share (EPS)
9.31
Revenue
184.9M
Net Profit
23.29M

About Novita Sa

Sector
Nonwoven Fabrics
Industry
Nonwoven Fabrics
Website
Headquarters
Zielona Gora, Pol
Founded
-
Novita Sa is listed in the Nonwoven Fabrics sector of the London Stock Exchange with ticker 0LWS. The last closing price for Novita was PLN46. Over the last year, Novita shares have traded in a share price range of PLN 46.00 to PLN 46.00.

Novita currently has 2,500,000 shares in issue. The market capitalisation of Novita is PLN115 million. Novita has a price to earnings ratio (PE ratio) of 4.94.

0LWS Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10046464600DE
40046464600DE
120046464600DE
260046464600DE
520046464600DE
1560046464600DE
2600046464600DE

0LWS - Frequently Asked Questions (FAQ)

What is the current Novita share price?
The current share price of Novita is PLN 46.00
How many Novita shares are in issue?
Novita has 2,500,000 shares in issue
What is the market cap of Novita?
The market capitalisation of Novita is PLN 115M
What is the 1 year trading range for Novita share price?
Novita has traded in the range of PLN 46.00 to PLN 46.00 during the past year
What is the PE ratio of Novita?
The price to earnings ratio of Novita is 4.94
What is the cash to sales ratio of Novita?
The cash to sales ratio of Novita is 0.62
What is the reporting currency for Novita?
Novita reports financial results in PLN
What is the latest annual turnover for Novita?
The latest annual turnover of Novita is PLN 184.9M
What is the latest annual profit for Novita?
The latest annual profit of Novita is PLN 23.29M
What is the registered address of Novita?
The registered address for Novita is UL. DEKORACYJNA 3, ZIELONA GORA, 65-722
What is the Novita website address?
The website address for Novita is novita.pl
Which industry sector does Novita operate in?
Novita operates in the NONWOVEN FABRICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Investor2014 Investor2014 4 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 9 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 10 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 14 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 17 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 17 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 20 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 23 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 25 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 26 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 27 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 28 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 30 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 44 minutes ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 45 minutes ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 45 minutes ago
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 48 minutes ago
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 50 minutes ago
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 50 minutes ago
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL
mrwhippy458 mrwhippy458 51 minutes ago
Somewhat true. Once it's at 250m OS, they need to bring that market cap up so we can start seeing dollars
ABQQ
CrossFireTrader CrossFireTrader 54 minutes ago
Actually Alocations are given to Dealerships based on how many Vettes they have sold in prior years 25 years ago I lived in Los Angeles and there was a small city Montclair about 10 15 south of Pasadena there was a Dealership there Richard Hibbard Chevrolet and he got more Vettes than anyone in the
GDVM
Roman516 Roman516 57 minutes ago
NWBO stock price manipulation NoGro,

Per your comments,
"NWBO share price dropped 58% i 52 weeks -- That means that longs are SELLING as they don't have confidence in the future of the company. No cash, vulture investors diluting shareholders, no real commercial prospects (UK i
NWBO
WATERFALL1 WATERFALL1 58 minutes ago
GVSI is uptrend stock already

Alligator opened the mouth on Dec.-06-2024
GVSI
StockItOut StockItOut 59 minutes ago
you're extrapolating. And youre attempt8ng to place it without understanding the reality of the contract in which its terms act.
XERI

Your Recent History

Delayed Upgrade Clock